Document And Entity Information [Abstract] Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Consolidated Balance Sheets Assets [Abstract] Assets Assets, Current [Abstract] Current assets Cash and Cash Equivalent Cash and cash equivalents Cash and cash equivalents Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Other Assets, Current Other receivables Assets, Current Total current assets Restricted Cash, Noncurrent Restricted cash Restricted cash Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Long-lived assets Operating Lease, Right-of-Use Asset Operating lease right-of-use asset Intangible Assets, Net (Excluding Goodwill) In-process research and development Goodwill Goodwill Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' deficit Liabilities, Current [Abstract] Current liabilities Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current, Total Deferred Compensation Liability, Current Accrued compensation Convertible Debt, Current Convertible Loan, current Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation and current convertible debt. Long-Term Debt, Current Maturities Other Than Convertible Debt Current Term debt, current Operating Lease, Liability, Current Less: current portion Current portion of operating lease liabilities Other Liabilities, Current Other current liabilities Liabilities, Current Total current liabilities Convertible Debt, Noncurrent Convertible Loan, non-current Secured Long-Term Debt, Noncurrent Term debt, non-current Operating Lease, Liability, Noncurrent Operating lease liabilities, net of current portion Noncurrent operating lease obligations Deferred Income Tax Liabilities, Net Deferred tax liability Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 12) Equity, Attributable to Parent [Abstract] Stockholders' deficit Common Stock, Value, Issued Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,644,703 and 37,145,720 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Equity, Attributable to Parent Balances Balances Total stockholders' deficit Liabilities and Equity Total liabilities and stockholders' deficit Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Consolidated Statements of Operations Statement [Table] Government Assistance, Type [Axis] Government Assistance, Type [Domain] Medical Technology Enterprise Consortium [Member]. Medical Technology Enterprise Consortium [Member] MTEC Grant Statement [Line Items] Revenue Not from Contract with Customer Grant and award revenue Operating Expenses [Abstract] Operating expenses Research and Development Expense (Excluding Acquired in Process Cost) Research and development Total research and development expenses General and Administrative Expense Total general and administrative expenses General and administrative Impairment of Leasehold Impairment expense Operating Expenses Total operating expenses Operating Income (Loss) Operating loss Other Expenses [Abstract] Other income (expense) Other Nonoperating Income Interest income Other Nonoperating Expense Interest expense Liabilities, Fair Value Adjustment Change in fair value, gain (loss) Change in fair value of the Convertible Loan Other Nonoperating Income (Expense) Other income (expense), net Total other income (expense), net Net income (loss) Net (loss) income Net Loss per Share Per share information: Earnings Per Share, Basic Net income (loss) per share, basic Weighted Average Number of Shares Outstanding, Basic Weighted average shares outstanding, basic Weighted average common shares outstanding, basic Earnings Per Share, Diluted Net loss per share, diluted Weighted Average Number of Shares Outstanding, Diluted Weighted average shares outstanding, diluted Weighted average common shares outstanding, diluted Consolidated Statements of Stockholders' Deficit Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Shares, Outstanding Balances (in shares) Balances (in shares) Stock Issued During Period, Value, New Issues Issuance of common stock under ATM, net Stock Issued During Period, Shares, New Issues Issuance of common stock under ATM, net (in shares) Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Shares, Exercised Exercise of stock options (in shares) Fair Value Adjustment of Warrants 2026 Debt and Warrant Amendments Debt and Warrant Amendments recorded as debt discount Restricted Stock, Value, Shares Issued Net of Tax Withholdings Issuance of Common Stock upon release of restricted stock units, net of tax withholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Issuance of Common Stock upon release of restricted stock units, net of tax withholdings (In shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense Consolidated Statements of Cash Flows Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract] Adjustments required to reconcile net loss to net cash used in operating activities: Depreciation Depreciation expense Depreciation Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Increase (decrease) fair value of liabilities. Increase Decrease Fair Value of Liabilities Change in fair value of the Convertible Loan Other Noncash Expense Non-cash interest expense The amount of increase (decrease) in operating lease right of use asset. Increase (Decrease) in Operating Lease Right Of Use Asset Change in right-of-use asset Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities Increase (Decrease) in Deferred Compensation Accrued compensation Increase (Decrease) in Operating Lease Liability Operating lease liability Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Investing activities: Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Financing activities: Proceeds from Issuance of Secured Debt Proceeds from issuance of term debt, net of issuance costs Proceeds from Issuance of Common Stock Proceeds from issuance of common stock under ATM, net Payment, Tax Withholding, Share-Based Payment Arrangement Payments for taxes related to net share settlement of equity awards Proceeds from exercise of warrants and stock options. Proceeds From Exercise Of Warrants And Stock Options Proceeds from exercise of stock options Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of cash flow information: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use asset obtained by assuming operating lease liabilities Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet: Organization and Description of the Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Description of the Business Liquidity And Going Concern [Abstract] Liquidity and Going Concern Substantial Doubt about Going Concern [Text Block] Liquidity and Going Concern Significant Accounting Policies Significant Accounting Policies [Text Block] Significant Accounting Policies Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Earnings Per Share [Text Block] Net Loss per Share Balance Sheet Details Property, Plant and Equipment Disclosure [Text Block] Balance Sheet Details Convertible Loan The entire disclosure for convertible debt. Convertible Debt Disclosure [Text Block] Convertible Loan Term Debt Long-Term Debt [Text Block] Term Debt Stockholders' Deficit Equity [Text Block] Stockholders' Deficit Equity Incentive Plans Share-Based Payment Arrangement [Text Block] Equity Incentive Plans Income Taxes Income Tax Disclosure [Text Block] Income Taxes Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Represents about award abstract. Grants and Awards represents about award text block. Award Text Block Grants and Awards Segment Reporting Segment Reporting Disclosure [Text Block] Segment Reporting Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Disclosure of accounting policy for significant accounting policies. Significant Accounting Policies [Policy Text Block] Significant Accounting Policies Use of Estimates, Policy [Policy Text Block] Use of Estimates Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risks and Certain Other Risks New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of assets and liabilities measured at fair value Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of estimated the fair value of its Convertible Loan using inputs Schedule of estimated the fair value of the warrants using inputs Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of changes in the fair value of its Convertible Loan Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Computation of Basic and Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Shares Outstanding Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment, net Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Accounts Payable and Accrued Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Financial Instrument [Axis] Financial Instruments [Domain] Warrant [Member] Outstanding warrants Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Changes in fair value of convertible loan Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Warrant Information Tabular disclosure of components of common shares reserved for future issuance. Schedule of Common Stock, Capital Shares Reserved for Future Issuance [Table Text Block] Schedule of Shares Reserved for Future Issuance Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Stock Option Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Schedule of Restricted Stock Awards and Restricted Stock Unit Activity Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Assumptions Used in the Black-Scholes Model Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Stock-Based Compensation Expenses Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Future Minimum Lease Payments Lease, Cost [Table Text Block] Schedule of Operating leases Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of certain segment information Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Organization and Description of the Business Cash and Cash Equivalent [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] This member represents 2023 credit agreement. Credit Agreement 2023 [Member] 2023 Credit Agreement This member represents 2024 credit agreement. Credit Agreement 2024 [Member] 2024 Credit Agreement This member represents 2025 credit agreement. Credit Agreement 2025 [Member] March 2025 Credit Agreement This member represents the August 2025 loan. August 2025 Loan [Member] August 2025 Loan This member represents the May 2026 loan. May 2026 Loan [Member] May 2026 Loan Counterparty Name [Axis] Counterparty Name [Domain] Innoviva Strategic Opportunities LLC [Member]. Innoviva Strategic Opportunities LLC [Member] Innoviva Strategic Opportunities LLC Debt Instrument [Axis] Debt Instrument, Name [Domain] Represents information pertaining to secured term loan. Secured Term Loan [Member] Secured term loan Sale of Stock [Axis] Sale of Stock [Domain] Represents the information pertaining to December 2025. Sales Agreement, December 2025 [Member] December 2025 Sales Agreement Cash and Cash Equivalents [Line Items] Liquidity and Going Concern Maximum aggregate offering price of shares that company may offer and sells. Stock Issued During Period, Value, Maximum Aggregate Offering Price Maximum aggregate offer price Debt Instrument, Face Amount Aggregate amount Debt Instrument, Interest Rate, Stated Percentage Interest rate (as a percent) Debt Instrument, Maturity Date Loan maturity date Fair Value, by Balance Sheet Grouping [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 Level 3 Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value Measurements Cash and Cash Equivalents, Fair Value Disclosure Investments in money market fund - financial assets, included in cash and cash equivalents Convertible Debt, Fair Value Disclosures Convertible Loan- financial liabilities Fair Value Measurement Inputs and Valuation Techniques [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Discount Rate [Member] Risk-free interest rate Measurement input used to determine value of probability of settlement scenarios. Probabilities of Settlement Scenarios [Member] Probabilities of settlement scenarios Measurement Input, Option Volatility [Member] Volatility Measurement Input, Expected Term [Member] Expected term (in years) Measurement Input, Risk Free Interest Rate [Member] Risk-free rate Risk-free interest rate Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurements Value of input used to measure debt instruments, including, but not limited to, convertible and non-convertible debt for the period. Debt Instrument, Measurement Input For The Period Debt instrument, measurement input, for the period Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Debt Instrument, Convertible, Conversion Price Price per share Share Price Common stock closing price Common stock closing price Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Convertible Loan at the end of the period Convertible Loan at the beginning of the period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Change in fair value No definition available. Earning Per Share Basic and Diluted [Abstract] Basic and diluted net loss per common share calculation: Amount of increase (decrease) from change in fair value of convertible debt. Change in Fair value of Convertible Debt Change in fair value of the Convertible Loan Net Income (Loss) Available to Common Stockholders, Diluted Net loss attributable to common stockholders, diluted Weighted Average Number of Shares Outstanding, Diluted, Adjustment Shares issuable upon the conversion of the Convertible Loan Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Equity Option [Member] Outstanding stock options Unvested stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met. Unvested Restricted Stock [Member] Unvested restricted stock units Shares issuable upon the conversion of Convertible Loan Shares issuable upon the conversion of Convertible Loan Shares issuable upon the conversion of the Convertible Loan Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities excluded from computation of diluted weighted shares outstanding Convertible Debt Convertible loan principal amount Interest Payable Accrued and unpaid interest Amount of property and equipment not in use included in laboratory equipment. Property and Equipment Not in Use Included in Laboratory Equipment Property and equipment not in use Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Machinery and Equipment [Member] Technology Equipment [Member] Laboratory equipment Office Equipment [Member] Office and computer equipment Property, Plant and Equipment, Other Types [Member] Furniture and Fixtures [Member] Office furniture and fixtures Land and Building [Member] Leasehold Improvements [Member] Leasehold improvements Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Gross Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Accounts Payable, Current Accounts payable Accrued liabilities clinical trial. Accrued Liabilities Clinical Trial Accrued clinical trial expenses Accounts Payable and Other Accrued Liabilities Other accrued expenses Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Term Loan Proceeds from qualified financing per agreement benchmark. Proceeds from Qualified Financing Per Agreement Benchmark Proceeds from qualified financing per agreement benchmark The percent of discount on share price for conversion of debt into shares of common stock. Debt Instrument, Conversion, Percent of Discount on Share Price Discount on share price for conversion Debt Instrument, Increase, Accrued Interest Accrued stated interest This member represents the 2026 credit agreement. Credit Agreement 2026 [Member] May 2026 Credit Agreement This member represents the 2026 Debt and Warrants Amendments. Debt and Warrants Amendments 2026 [Member] 2026 Debt and Warrants Amendments Long-Term Debt, Fair Value Recognized at fair value Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Debt issuance cost and debt discount Debt Issuance Costs, Net Debt issuance costs Proceeds from (Repayments of) Secured Debt Proceeds from secured debt Debt Instrument, Interest Rate, Effective Percentage Effective interest rate (as a percent) Measurement Input, Expected Dividend Rate [Member] Expected dividend yield Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Exercise Price One [Member]. Exercise Price One [Member] Exercise Price $3.25, January 26, 2031 Exercise Price Two [Member]. Exercise Price Two [Member] Exercise Price $3.25, January 26, 2031, 2 Exercise Price Three [Member]. Exercise Price Three [Member] Exercise Price $5.00, January 26, 2031 Exercise Price Four [Member]. Exercise Price Four [Member] Exercise Price $5.00, January 26, 2031, 2 Exercise Price Five [Member]. Exercise Price Five Exercise Price 1680.00 Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Class of Warrant or Right, Outstanding Warrants outstanding Shares Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise Price Warrants and Rights Outstanding, Maturity Date Expiration Date Number of warrants or rights outstanding which have an extended expiration date. Class Of Warrant or Right, Outstanding, Extended Expiration Date Shares with extended expiration date Employee Stock Ownership Plan (ESOP) Name [Axis] Employee Stock Ownership Plan (ESOP), Plan [Domain] Equity Incentive Plan 2016 [Member] Equity Incentive Plan 2016 [Member] Equity Incentive Plan 2016 Restricted Stock Units (RSUs) [Member] Restricted stock unit Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Shares, Balance Ending Shares, Balance Beginning Stock options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding at end of period (in shares) Outstanding at beginning of period (in shares) Unvested restricted stock units Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares Shares issuable under the Employee stock purchase plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Shares available for future grants under the 2016 Plan Number of shares issuable upon conversion of convertible debt. Shares Issuable Upon Conversion Of Convertible Debt Shares issuable upon the conversion of the Convertible Loan Common Stock, Capital Shares Reserved for Future Issuance Total shares reserved Reserved shares Employee Stock Ownership Plan (ESOP) [Table] Stock Options And Restricted Stock Awards [Member]. Stock Options And Restricted Stock Awards [Member] Stock Options And Restricted Stock Awards Employee Stock Ownership Plan (ESOP) Disclosures [Line Items] Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation cost related to unvested options Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted-average remaining period for recognition of compensation costs related to unvested options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Shares, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Shares, Forfeited/Cancelled/Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest at June 30, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable at December 31, 2025 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Outstanding Ending Weighted Average Exercise Price, Outstanding Beginning Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Forfeited/Cancelled/Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Vested and expected to vest at June 30, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price, Exercisable at June 30, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term (Years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term (Years), Vested and expected to vest at June 30, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term (Years), Exercisable at June 30, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding Ending Aggregate Intrinsic Value, Outstanding Beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Aggregate Intrinsic Value, Exercised Share based compensation arrangement by share based payment award options forfeited in period intrinsic value. Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Intrinsic Value Aggregate Intrinsic Value, Forfeited/Cancelled/Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate Intrinsic Value, Vested and expected to vest at June 30, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value, Exercisable at June 30, 2026 Restricted Stock [Member] Restricted stock awards Plan Name [Axis] Plan Name [Domain] Represents information pertaining to C3J 2016 stock plan. C3J Stock Plan 2016 [Member] C3J Stock Plan 2016 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Avg Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Outstanding at end of period (in dollars per share) Outstanding at beginning of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested (in dollars per shares) Class of Stock [Axis] Class of Stock [Domain] Contract that gives the holder the right, but not the obligation, either to purchase or to sell a certain number of shares of stock at a predetermined price for a specified period of time. Common Stock Options [Member] Common Stock Options Measurement Input, Price Volatility [Member] Expected volatility Value of input used to measure investment in equity security measured at fair value for the period. Equity Securities Measurement Input Fair value input, equity securities Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Expense Total stock-based compensation Effective Income Tax Rate Reconciliation [Table] Effective Income Tax Rate Reconciliation [Line Items] Income Tax Expense (Benefit) Income tax expense (benefit) Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Amount of annual base rent for operating lease. Operating Lease Base Annual Annual base rent for operating lease Annual increase in rent percentage. Annual Increase in Rent Percentage Annual increase in rent percentage Letters of Credit Outstanding, Amount Standby letter of credit Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Lease term Amount of allowance for tenant improvements receivable. Allowance For Tenant Improvements Receivable Allowance for tenant improvements Operating Lease, Expense Rent expense under operating leases Variable Lease, Payment Variable lease payment Lessee, Operating Lease, Discount Rate Discount rate Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 (remaining) Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Lessee, Operating Lease, Liability, to be Paid, after Year Five Thereafter Lessee, Operating Lease, Liability, to be Paid Total minimum lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: amount representing interest Operating Lease, Liability Present value of operating lease obligations Operating Lease, Payments Operating cash flows from operating leases Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term, years Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate, % Government Assistance [Table] Represents the member information pertaining to award agreement (the "Award Agreement") with CFF. Award Agreement with Cystic Fibrosis Foundation [Member] CFF Therapeutics Development Award Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single Reportable Segment [Member] Single Reportable Segment Government Assistance [Line Items] Government Assistance, Award Amount Revenue from grants Government Assistance, Asset, Increase, Current Increase in expected revenue from grants Government Assistance, Asset, Increase, Current, Statement of Financial Position [Extensible Enumeration] Government Assistance, Income, Increase (Decrease) Grant revenue from the MTEC Agreement Grants Receivable, Current Grants receivable The amount of cash inflow associated with government grants. Proceeds from Government Grants Proceeds from governments grants Represents the period for which the company ceases to use commercially reasonable efforts directed to the development of the product. Award Agreement, Interruption Period Award agreement interruption period Schedule of Segment Reporting Information, by Segment [Table] Geographical [Axis] Geographical [Domain] UNITED STATES United States Segment Reporting Information [Line Items] Segment Reporting Number of Operating Segments Number of operating segments Number of Reportable Segments Number of reportable segments Percentage of long lived assets In geographical location. Percentage of Long Lived Assets In Geographical Location Percentage of long-lived assets Project [Axis] Project [Domain] Represents information pertaining to Non-cystic fibrosis bronchiectasis. Non-Cystic Fibrosis Bronchiectasis [Member] AP-PA02: Non-Cystic Fibrosis Bronchiectasis Represents information pertaining to Cystic fibrosis. Cystic Fibrosis [Member] AP-PA02: Cystic Fibrosis Represents information pertaining to Bacteremia. Bacteremia [Member] AP-SA02: Bacteremia Represents information pertaining to Prosthetic joint infection. Prosthetic Joint Infection [Member] AP-SA02: Prosthetic Joint Infection Amount of external research and development expenses incurred during the period. External Research and Development Expense External research and development expenses Amount of external research and development expense not allocated by projects. Unallocated External Research and Development Expense Expenses not allocated by projects Amount of total external research and development expenses incurred during the period. External Research and Development Expense, Total Total external research and development expenses Amount of personnel expenses incurred in connection with research and development. Research and Development, Personnel Expense Research and development personnel expenses Other Research and Development Expense Other research and development expenses Labor and Related Expense General and administrative personnel expenses Other General and Administrative Expense Other general and administrative expenses Subsequent Events